Skip to content
★ Sign in to follow
VW
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 17 Jul 2023 for GSK plc, €828.

Filing timeline

BuySale
V Whyte

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

  • GSK plc 5 purchases · last 17 Jul 2023

V Whyte: trading record in brief

This profile gathers the share dealings of V Whyte in GSK plc. The record holds 13 filings, for trades running from 9 August 2022 to 14 July 2023.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 17 July 2023 with a share grant (€828) in GSK plc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to V Whyte

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Company SecretaryExecutivesGSK plc
    708 GBP29RNS
    53 shares@ £13.35337.0% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-10
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    Company SecretaryExecutivesGSK plc
    494 GBP28RNS
    37 shares@ £13.349725.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-13
    Canonical exit: 11 Oct 2023 (T+90)
  • ▲
    Company SecretaryExecutivesGSK plc
    225 GBP26RNS
    17 shares@ £13.257611.8% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-16
    Canonical exit: 12 Oct 2023 (T+90)
  • ▲
    Company SecretaryExecutivesGSK plc
    235 GBP26RNS
    18 shares@ £13.067212.4% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-8
    Canonical exit: 9 Oct 2023 (T+90)
  • ▲
    Company SecretaryExecutivesGSK plc
    248 GBP26RNS
    18 shares@ £13.796712.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-8
    Canonical exit: 7 Sept 2023 (T+90)

5 of 5 declarations